Nautilus Biotechnology, Inc. (NAUT)
2.83
-0.06
(-2.08%)
USD |
NASDAQ |
Feb 20, 16:00
2.83
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology EPS Diluted (Quarterly) : -0.1075 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nephros, Inc. | 0.0305 |
| Prelude Therapeutics, Inc. | -0.2591 |
| Pyxis Oncology, Inc. | -0.3517 |
| ProKidney Corp. | -0.122 |
| Neumora Therapeutics, Inc. | -0.3507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.57M |
| Total Expenses (Quarterly) | 13.57M |
| Enterprise Value | 260.60M |
| Earnings Yield | -17.60% |
| Normalized Earnings Yield | -17.60 |